The following are SVS corporate contributors for the April 1, 2011 - March 31, 2012 fiscal year:
- Abbott Vascular ($150,000)
- Boston Scientific ($70,000)
- Cook Medical, Inc. ($130,000)
- Cordis Corporation ($60,000)
- Covidien ($15,000)
- CryoLife, Inc. ($1,500)
- Endologix, Inc. ($20,000)
- EV3 ($15,000)
- Gore & Associates ($100,000)
- Lantheus Medical Imaging, Inc. ($20,000)
- Lifelike Bio Tissue, Inc. ($3,500)
- Medtronic ($155,000)
- Terumo ($3,000)
- Tri-Medics ($2,500)
- Zonare Medical Systems, Inc. ($7,000)
Twenty-two percent of SVS operating revenue for the fiscal year ending March 31, 2012 was derived from industry support. Ten percent was from industry support for education, research, and public outreach programs; the remaining 12 percent was from industry exhibits and advertising at the Vascular Annual Meeting.
Posted October 2012